DOCSLIB.ORG

Hemp: Positioning Yourself As the Truth Expert

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Hemp: Positioning Yourself As the Truth Expert 10/21/19 1 Hemp: Positioning Yourself as the Truth Expert Hyman Phelps & McNamara, P.C. Karla L. Palmer, Esq. Director 2 1 10/21/19 LEGAL NOTE • Nothing set forth in this slide deck or anything communicated By me constitutes the rendering of legal advice • There are no relevant financial relationships with ACCME- defined commercial interests for anyone who was in control of the content of the activity. 3 Pharmacist & Pharmacy Technician Learning Objectives • Discuss federal and state laws related to hemp-based products and associated risks and opportunities. • Identify potential uses, formulation considerations, and potential side effects of hemp. • DescriBe strategies for educating prescriBers, patients, and the community on hemp. 4 2 10/21/19 Cannabis as a Controlled Substance Under Federal Law • Regulation Depends on THC Content and Plant Material • The CSA defines “marijuana” as: • All parts of the Cannabis sativa L. plant whether growing or not; • Its seeds; • Resin extracted from any part of the plant; and • Every compound, manufacture, salt, derivative, mixture or preparation of the plant, its seeds or resin. • Marijuana is a Schedule I controlled substance. 5 Cannabis as a Controlled Substance Under Federal Law (cont’d) The Controlled SuBstances Act (CSA) definition of “marijuana” expressly excludes: 1. Hemp (cannaBis and derivatives with a THC content < 0.3% By dry weight) 2. The following plant parts and products derived therefrom: • Mature stalks of the plant; • FiBer produced from such stalks; • Oil or cake made from the seeds; • Any other compound, manufacture, salt, derivative, mixture or preparation of the mature stalks (except extracted resin) fiBer, oil or cake; and • sterilized seeds incapaBle of germination. 6 3 10/21/19 Hemp-Related Legislation • Agricultural Act of 2014 • Authorized institutions of higher education and state departments of agriculture to grow or cultivate industrial hemp for research under an agricultural pilot program or for other agricultural or academic research. • “Industrial hemp” was defined as the Cannabis plant and any part of the plant with a THC concentration of not more than 0.3 % on a dry weight Basis. • Did not authorize general commercial activity. • Hemp Farming Act of 2018 • Proposed to remove “hemp” from the CSA definition of “marijuana” and exclude THC in “hemp” from control. • Proposed to define “hemp” as the Cannabis plant and any part with a THC concentration of not more than 0.3 % on a dry weight Basis. 7 *** Agriculture Improvement Act of 2018 (a/k/a “The Farm Bill”)*** • Adopted the definition of “hemp” proposed in Hemp Farming Act • Authorized interstate commerce in hemp-derived products • EstaBlished a framework for regulation of hemp production by USDA pursuant to USDA-administered plans or state plans approved By USDA • Left it up to states to decide whether to allow hemp production and marketing within their Borders • Disclaimed any intent to affect or modify the Federal Food, Drug and Cosmetic Act (FD&C Act) 8 4 10/21/19 Then FDA Commissioner Gottlieb’s Statement: • DecemBer 2018 • Recognizes “hemp” as defined is no longer controlled under federal law • FDA still has authority to regulate cannaBis and cannaBis-derived compounds under the FD&C Act. • Aware of growing interest in CBD • Continue to Be concerned aBout drug claims of therapeutic Benefit made about unapproved products https://www.fda.gov/news-events/press-announcements/statement-fda-commissioner-scott-gottlieB-md-signing-agriculture- improvement-act-and-agencys 9 Then FDA Commissioner Gottlieb’s Statement: • “Selling unapproved products with unsubstantiated therapeutic claims is not only a violation of the law, But also can put patients at risk, as these products have not Been proven to Be safe or effective. This deceptive marketing of unproven treatments raises significant puBlic health concerns, as it may keep some patients from accessing appropriate, recognized therapies to treat serious and even fatal diseases.” • “… it’s unlawful under the FD&C Act to introduce food containing added CBD or THC into interstate commerce, or to market CBD or THC products as, or in, dietary supplements, regardless of whether the substances are hemp-derived. This is because both CBD and THC are active ingredients in FDA-approved drugs and were the suBject of suBstantial clinical investigations Before they were marketed as foods or dietary supplements.” 10 5 10/21/19 Then FDA Commissioner Gottlieb’s Statement: • Most importantly: “We’ll take enforcement action needed to protect puBlic health against companies illegally selling cannabis and cannaBis-derived products that can put consumers at risk and are Being marketed in violation of the FDA’s authorities .…” 11 FD&C Act: Prohibited Acts • The FDCA is a strict liability statute that specifies a numBer of prohibited acts • Examples of prohiBited acts: • introduction into interstate commerce of an adulterated food • introduction into interstate commerce of an unapproved, adulterated, misBranded drug • ProhiBited acts are potentially punishaBle By civil and criminal penalties 12 6 10/21/19 FDA Enforcement Actions • CBD companies in question allegedly marketed their products for, among other things, Alzheimer’s disease, fiBromyalgia, inflammation, skin conditions, autoimmune disorders, anxiety, cancer pain, PTSD and depression, to name a few symptoms. • Companies are making food, dietary supplements, and cosmetic products, as well as products for pets (CBD for dogs). 13 FDA Enforcement Actions • CBD isolate product not permissiBle. • Products are misBranded, unapproved new human or animal drugs. • FDA says the products are marketed as dietary supplements, but do not meet the definition of a dietary supplement. • Can’t say CBD fights cancer and has an anti-tumor effect. • Use of a nutrition facts panel on a CBD oil is inappropriate Because the oil is a food to which a drug (CBD) has been added (FDCA prohiBits the introduction into interstate commerce of any food to which a drug has been added). 14 7 10/21/19 Federal Trade Commission • Also issued warning letters in 2019: • Claims must have “competent and reliaBle scientific evidence to support such claims.” • Claims that have drawn scrutiny: • CBD “works like magic” against “even the most agonizing pain.” • “Clinically proven” to treat diseases like cancer and multiple sclerosis, • Reference to “thousands of hours of research” the firm has participated in, in conjuncture with Harvard University. 15 Federal Trade Commission (cont’d) • “Miracle pain remedy” for a variety of chronic and acute pain, autism, anorexia, Bipolar disorder, post-traumatic stress disorder, schizophrenia, anxiety, depression, Alzheimer’s disease, Lou Gehrig’s Disease (ALS), stroke, Parkinson’s disease, epilepsy, traumatic Brain injuries, diaBetes, Crohn’s disease, psoriasis, MS, asthma, fiBromyalgia, cancer, and AIDS. • Highly effective at treating “the root cause of most major degenerative diseases, including arthritis, heart disease, fiBromyalgia, cancer, asthma, and a wide spectrum of autoimmune disorders.” • CBD oil, gummies, tinctures • FTC cautions: Unproven health claims could result in a federal injunction and forced reimBursements to customers who purchased the products. 16 8 10/21/19 FD&C Act: Intended Use • “Intended use” determines regulatory status • An article is potentially a drug or medical device if it is intended to • Affect a structure or function of the body (unless it’s food) • Treat, cure, prevent, mitigate, or diagnose a disease • Structure/function claims are permitted for dietary supplements and food, but not cosmetics • “Disease claims are not permitted for dietary supplements, food, or cosmetics” 17 BUT…. CBD is an “FDA-Approved Drug” • FDA approved Epidiolex, an oral CBD solution derived from cannaBis, for treatment of seizures associated with Lennox-Gastaut and Dravet syndromes on June 25, 2018. • On SeptemBer 28, 2018, DEA rescheduled FDA-approved drugs that contain CBD derived from cannaBis with no more than 0.1 % THC in Schedule V. • NOT SO FAST… • DEA closed its Epidiolex Federal Register scheduling notice stating: • “[A]ny material, compound, mixture, or preparation other than Epidiolex that falls within the CSA definition of marijuana set forth in 21 U.S.C. 802(16), including any non-FDA-approved CBD extract that falls within such definition, remains a schedule I controlled suBstance under the CSA.” 18 9 10/21/19 Next: CBD as a Dietary Supplement: “The Exclusionary Clause” • The definition of “dietary supplement” excludes an article: • Approved as a drug, or • Authorized for investigation as a new drug for which substantial clinical investigation shave been instituted and made public, unless… • The article was previously marketed as a dietary supplement or food (prior marketing exception) • FDA can issue a regulation voiding the exclusion 19 FDA: CBD is “Excluded” • Based on available evidence, CBD products are excluded from the statutory definition of “dietary supplement” • The existence of substantial clinical investigations regarding CBD have been made public, e.g., studies of GW Pharmaceuticals’ Sativex and Epidiolex • The prior marketing exception does not apply, based on available evidence • FDA has encouraged submission of relevant evidence • FDA has indicated willingness to consider rulemaking 20 10 10/21/19 State Regulation of CBD • Some states’ definition of “marijuana” is Broader than the federal CSA definition, so more products are regulated as controlled suBstances. • It follows that CBD may or
Load more

Recommended publications
  • Istituto Di Economia E Finanza Public
    2527) ISTITUTO DI ECONOMIA E FINANZA - PUBLIC FINANCE RESEARCHPAPERS (ISSN 2284 THE CANNABIS SOCIAL MARKET MARCO ROSSI Public Finance Research Papers E-PFRP N. 43 2020 Marco Rossi DISSE-Sapienza Università di Roma P.le A. Moro, 5 00185 ROMA Si prega di citare così:Marco Rossi (2020), “The cannabis social market”, Public Finance ResearchPapers, Istituto di Economia e Finanza, DIGEF, Sapienza University of Rome, n. 43 (https://www.dsge.uniroma1.it/pubblicazioni/istituto- economia-e-finanza/public-finance-research-papers). 2 E-PFRP N. 43 Marco Rossi The cannabis social market 3 E-PFRP N. 43 Introduction Here, we define the market where the traders are friends, and the transactions are minimally commercially oriented, as the “cannabis social market”. In order to define the cannabis “social market”, we add the study of the cannabis “social demand” to what has been already defined in the literature as “social supply” (Hough et al. 2003). We think that the study of the demand side is very important because in this market it looks like that trading is demand-driven, more than profit- oriented. Actually, the main (alleged) motivation for selling cannabis to a friend is to satisfy his need (“to help out a friend”), more than to gain a monetary profit. In the cannabis social market, the short side of the market is the demand side, that is the quantity traded is the quantity demanded by consumers. Instead, street dealers supply is profit-oriented, therefore the street dealers’ commercial attitude is more aggressive: they are named “pushers” because they try to motivate potential buyers.
    [Show full text]
  • Medical Marijuana: the Impact on the Workplace
    9/1/2020 MEDICAL MARIJUANA: THE IMPACT ON THE WORKPLACE John A. McCreary Charlotte Katzenmoyer Adam L. Santucci Babst Calland Executive Director McNees Wallace & Nurick Phone: (412)394.5400 Capital Region Water Phone: (717)237.5388 [email protected] [email protected] [email protected] www.McNeesLaw.com OVERVIEW • The federal landscape • How the PA Medical Marijuana Law Works • Employment aspects of PA Medical Marijuana Law • What have the courts said (so far) www.McNeesLaw.com 1 9/1/2020 THE FEDERAL LANDSCAPE Marijuana ‐ Status Across the U.S. • Legal for recreational use –11 states plus DC • Legal for medical use –33 states plus DC • Low THC/High CBD laws –14 states • Federal Law • Controlled Substances Act (CSA) – Schedule I drug • DOJ Memo • Rohrabacher‐Farr/Blumenauer amendment • Farm Bill – legalization of hemp www.McNeesLaw.com THE FEDERAL LANDSCAPE Drug Free Workplace Act of 1988 • Applies to Federal contractors and grantees • Requires covered organizations to provide a “drug‐free workplace” by: • Publishing a policy statement • Establishing an awareness program • Notifying employees of their obligations • Notifying the granting agency of any violations • Imposing penalties • Standard – “good faith effort to maintain a drug‐free workplace.” • Penalties for lack of compliance –payments and/or grant may be suspended/terminated www.McNeesLaw.com 2 9/1/2020 MEDICAL MARIJUANA & DRUG TESTING Does Legalization Affect Drug Testing? • Testing generally governed by federal law • DOT Regulations •
    [Show full text]
  • Has the Marijuana Classification Under the Controlled Substances Act Outlived Its Definition?
    Has the Marijuana Classification Under the Controlled Substances Act Outlived Its Definition? JUDGE MARY A. CELESTE & MELIA THOMPSON-DUDIAK† I. INTRODUCTION Under the Control Substances Act (“CSA”), marijuana is currently scheduled as an “I” drug.1 In a classification of “V” schedules, “I” is considered the most dangerous because it is deemed to have a “high potential for abuse” and “no medical value.”2 It ranks alongside other substances such as heroin and phencyclidine (“PCP”), thereby signifying that the federal government considers marijuana more dangerous than cocaine (Schedule II) and Xanax (Schedule IV).3 According to the CSA, any violation of a substance listed as a schedule “I” drug is subject to the harshest penalties.4 Accordingly, using, manufacturing, importing, or distributing marijuana could result in various penalties.5 Individuals involved in marijuana businesses can receive up to five years in prison and simple possession with no intent to distribute is a misdemeanor with fines ranging from $250,000 to $1 million,6 or punishable by up to one year in prison and a minimum fine † Judge Mary A. Celeste (ret.) sat on the Denver County Court bench 2000-2015. She was the Presiding Judge 2009-10 and the co-founder of the Denver County Court Sobriety Court. She is currently a law school professor teaching Marijuana and the Law at California Western School of Law. She is a national expert and speaker on the topic of marijuana and has also written on the topic. Please visit her website at judgemaryceleste.com for more information. Melia Thompson-Dudiak’s work aims to empower women and people of color by exploring issues of social justice, global public policy, and equity.
    [Show full text]
  • Il Mercato Sociale Della Cannabis: Un'analisi Economica
    ISSN 2385-2755 DiSSE Working papers [online] Il mercato sociale della cannabis: un’analisi economica Marco Rossi N. 13/2020 SAPIENZA - UNIVERSITY OF ROME P.le Aldo Moro n.5 – 00185 Roma T(+39) 0649910563 CF80209930587 – P.IVA 02133771002 Il mercato sociale della cannabis: un’analisi economica. Marco Rossi Dipartimento di Scienze Sociali ed Economiche (Disse); Facoltà di Scienze Politiche, Sociologia e Comunicazione; Università la Sapienza, Roma. [email protected] Abstract In questo saggio definiamo “mercato sociale della cannabis” l’istituzione in cui avvengono scambi di cannabis tra amici “marginalmente orientati al profitto”. Mentre l’offerta “sociale” di cannabis è già stata studiata in letteratura, in questo saggio si analizza il lato della domanda di questo mercato. Pertanto, si sviluppa un modello teorico del mercato sociale della cannabis, basato sull’ipotesi che le transazioni siano investimenti in uno specifico capitale sociale. Inoltre, altre ipotesi circa le caratteristiche distintive di questa istituzione sono derivate da una analisi comparata con il mercato dei venditori professionisti. In particolare, l’ipotesi dell’esistenza di una correlazione positiva tra grado di integrazione sociale e frequentazione del mercato sociale è empiricamente verificata,grazie ad una indagine su un campione di consumatori. Infine, sulla base di un approccio costi-benefici, si deriva una implicazione normativa di questo modello. Abstract We define the market where the traders are friends, and the transactions are minimally commercially oriented, as the “cannabis social market”. Therefore, we add the study of the social cannabis demand to the “cannabis social supply”, already defined in the literature. In our theoretical model, transactions in the cannabis social market are investments in a specific social capital, and the distinctive features of this institution are derived by comparison with street dealing.
    [Show full text]
  • Exposure & Health Effects of Pesticides Used in the Cultivation Of
    We Don’t Rinse Cannabis PESTICIDES & PUBLIC HEALTH Exposure & Health Effects of Pesticides Used in the Cultivation of Cannabis Leslie McAhren, MPH, MFA, DrPH (expected May 2020) https://youtu.be/6z2HNCIsHzg Outline • Important Terms/Concepts • Detection of Pesticides in Cannabis • Lessons/Research From Tobacco & Pesticides • Setting the Research & Policy Trajectory for the Ideal Cannabis Pesticide Post, 2019 Typical Pests in Cannabis Cultivation • Insects • Mites • Thrips • Fungus • Powdery mildew Routes of Ingestion for Cannabis Abrams et al, 2007 Cannabis Forms & The Extraction Process Pyrolysis • decomposition brought about by high temperatures What is a Pesticide? • A pesticide is any substance intended to control, destroy, repel, or attract a pest • This includes insecticides, fungicides, herbicides, rodenticides and sanitizers. USA Pesticide Regulation • The Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) is a United States federal law • U.S. system of pesticide regulation to protect applicators, consumers, and the environment • The EPA is responsible for regulating pesticides under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) and the Food Quality Protection Act (FQPA) Timing of Pesticides within the Cultivation Lifecycle • Spraying at different points in the lifecycle has different implications • Spraying during the flowering phase ends up on the finished product • How do we know? Pesticides Have been Detected in Cannabis Smoke • Chemical residues present on the cannabis flowers directly transfer into
    [Show full text]
  • Hemp As an Agricultural Commodity
    Hemp as an Agricultural Commodity Renée Johnson Specialist in Agricultural Policy June 22, 2018 Congressional Research Service 7-5700 www.crs.gov RL32725 Hemp as an Agricultural Commodity Summary Industrial hemp is an agricultural commodity that is cultivated for use in the production of a wide range of products, including foods and beverages, cosmetics and personal care products, nutritional supplements, fabrics and textiles, yarns and spun fibers, paper, construction and insulation materials, and other manufactured goods. Hemp can be grown as a fiber, seed, or other dual-purpose crop. However, hemp is also from the same species of plant, Cannabis sativa, as marijuana. As a result, production in the United States is restricted due to hemp’s association with marijuana, and the U.S. market is largely dependent on imports, both as finished hemp-containing products and as ingredients for use in further processing (mostly from Canada and China). Current industry estimates report U.S. hemp product sales at nearly $700 million annually. In the early 1990s there was a sustained resurgence of interest to allow for commercial hemp cultivation in the United States. Several states conducted economic or market studies and initiated or enacted legislation to expand state-level resources and production. Congress made significant changes to federal policies regarding hemp in the 2014 farm bill (Agricultural Act of 2014 (P.L. 113-79, §7606). The 2014 farm bill provided that certain research institutions and state departments of agriculture may grow hemp under an agricultural pilot program. The bill further established a statutory definition for industrial hemp as “the plant Cannabis sativa L.
    [Show full text]
  • Cannabis and Life Sciences
    INITIATING COVERAGE Institutional Equity Research: LIFE SCIENCES January 7, 2019 Cannabis and Life Sciences Thematic Review of the Canadian, US, and International Cannabis Markets, and the Cannabinoid-derived Pharmaceutical Space Initiating Coverage on 3 Cannabis and Life Sciences Companies: . Valens GroWorks Corporation (VGW-CNQ, Outperform, $5.00 TP) . Auxly Cannabis Group Inc. (XLY-TSXV, Outperform, $1.50 TP) . GW Pharmaceuticals PLC (GWPH-US, Outperform, US$160 TP) David M. Kideckel, PhD, MBA Analyst, Managing Director 647 776 8240 [email protected] Matthew Pallotta, CPA, CA, MBA Associate 647 776 8236 [email protected] Kevin Hoang, CPA, CA Associate 647 776 8220 [email protected] Regulatory Disclosures and policy on the dissemination of research: www.altacorpcapital.com ALTACORP CAPITAL INC. INSTITUTIONAL EQUITY RESEARCH: LIFE SCIENCES Table of Contents Our Investment Thesis ................................................................................................. 3 Understanding the Cannabis Plant ......................................................................................... 4 Industry Overview ......................................................................................................... 5 Canada ................................................................................................................................... 5 Overview of Legal Framework .............................................................................................. 6 Cannabis Market Forecast
    [Show full text]
  • Download Impact Report
    THIS PAGE INTENTIONALLY LEFT BLANK ACKNOWLEDGEMENTS We give special thanks to all who provided research, resources and data for this report. We also give thanks to the agencies that provided instrumental data for this report. California Department of Justice Bureau of Investigation (CA DOJ/BI Californians for Drug Free Youth (CADFY) California Highway Patrol (CHP) California National Guard Counterdrug Task Force (CNG CDTF) Center for Community Research, San Diego (CCR) Central Valley California High Intensity Drug Trafficking Area (CVC HIDTA) Health Information Resources Center, Healthcare Information Division, Office of Statewide Health Planning and Development (OSHPD) of California Imperial Valley Drug Coalition Law Enforcement Coordination Center (IVDC/LECC) Dr. Mourad Gabriel, Research Wildlife Biologist, United States Forest Service (USFS) Los Angeles High Intensity Drug Trafficking Area (LA HIDTA) Los Angeles Regional Criminal Information Clearinghouse (LA CLEAR) Marijuana Prevention Initiative, San Diego County (MPI) National Marijuana Initiative (NMI) Northern California High Intensity Drug Trafficking Area/ Northern California Regional Intelligence Center (NC HIDTA/ NCRIC) Rocky Mountain High Intensity Drug Trafficking Area (RM HIDTA) San Diego Association of Governments (SANDAG) San Diego/ Imperial Valley High Intensity Drug Trafficking Area (SDI HIDTA) San Diego Law Enforcement Coordination Center (SD LECC) United States Postal Inspection Service (USPIS) Dr. Greta Wengert, MS, PhD (Integral Ecology Research
    [Show full text]
  • An Overview of Industrial Hemp Law in the United States
    University of the District of Columbia Law Review Volume 22 Issue 1 Article 7 May 2020 An Overview of Industrial Hemp Law in the United States Marc Adesso Pirjin Laser Alex Mills Follow this and additional works at: https://digitalcommons.law.udc.edu/udclr Part of the Agriculture Law Commons, and the Food and Drug Law Commons Recommended Citation Marc Adesso, Pirjin Laser & Alex Mills, An Overview of Industrial Hemp Law in the United States, 22 U.D.C. L. Rev. 85 (2020). Available at: https://digitalcommons.law.udc.edu/udclr/vol22/iss1/7 This Article is brought to you for free and open access by Digital Commons @ UDC Law. It has been accepted for inclusion in University of the District of Columbia Law Review by an authorized editor of Digital Commons @ UDC Law. AN OVERVIEW OF INDUSTRIAL HEMP LAW IN THE UNITED STATES Marc Adesso, Attorney at Waller Lansden Dortch &Davis, LLP Pirjin Laser, Attorney at Waller Lansden Dortch &Davis, LLP Alex Mills, Director of Operations and General Counsel at High Plains Crop Production LLC* Since the writing of this note, the Agricultural Improvement Act of 2018 (the "Farm Bill") was signed into law by President Trump on December 20, 2018. Thus, the note below does not account for the passage of the Farm Bill and resulting change in federal law. What follows is a brief summary of sections of the Farm Bill and its relation to hemp: The Farm Bill legalizes hemp by defining it as an agricultural commodity under federal law. Removed from this new definition of hemp, are the parts of the cannabis plant that make it illegal under the Controlled Substances Act of 1970.
    [Show full text]
  • Charlotte's Web Holdings, Inc
    A copy of this second amended and restated preliminary prospectus has been filed with the securities regulatory authorities in each of the provinces of Canada (other than Qu´ebec) but has not yet become final for the purpose of the sale of securities. Information contained in this second amended and restated preliminary prospectus may not be complete and may have to be amended. The securities may not be sold until a receipt for the prospectus is obtained from the securities regulatory authorities. No securities regulatory authority has expressed an opinion about these securities and it is an offence to claim otherwise. This prospectus constitutes a public offering of securities only in those jurisdictions where such securities may be lawfully offered for sale and therein only by persons permitted to sell such securities. See ‘‘Plan of Distribution’’. These securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the ‘‘U.S. Securities Act’’), or any securities laws of any state of the United States and may not be offered or sold in the United States except in compliance with the registration requirements of the U.S. Securities Act and any applicable state securities laws or pursuant to an applicable exemption therefrom. This prospectus does not constitute an offer to sell or a solicitation of an offer to buy any of the securities offered hereby within the United States. See ‘‘Plan of Distribution’’. SECOND AMENDED AND RESTATED PRELIMINARY PROSPECTUS (amending and restating the amended and restated preliminary prospectus dated July 13, 2018, which amended and restated the preliminary prospectus dated June 25, 2018) Initial Public Offering and Secondary Offering August 22, 2018 12JUL201809040256 CHARLOTTE’S WEB HOLDINGS, INC.
    [Show full text]
  • Maine Marijuana Education Toolkit
    Marijuana Education Toolkit Preventing Underage and High Risk Use July 2020 About This Toolkit The use, sale, and possession of marijuana for those 21 and over is legal in Maine. On November 8, 2016, Maine voters approved Question 1 allowing the legalized use, retail sale, and taxation of marijuana. In 2019, licenses for adult use retail sale, manufacture, and operations were made available. Maine has a robust community of public health professionals who use passion and expertise in their work to prevent tobacco and substance use in their communities, and who know it will take a comprehensive, multi-faceted approach to address the increased visibility and shifting norms that accompany legalization of adult use marijuana. This marijuana toolkit aims to provide community members and prevention educators with essential information and supportive resources. This toolkit is intended to be included in broader community prevention education efforts. Preventing initiation of marijuana use among young people, as well as limiting problematic use, will take the effort of entire communities. This toolkit: • Provides information on health impacts, legal considerations, safety issues, and delves into elements of the cannabis plant, including the psychoactive and non-psychoactive components. • Uses cannabis and marijuana interchangeably, however the legal term for the product regulated and licensed in the state of Maine is marijuana. • Refers to adult use (rather than recreational use) in reference to use and possession for those over 21. Federally, marijuana remains a Schedule 1 Drug and continues to be illegal under federal law even though the state of Maine has voted to legalize adult use and retail sales.
    [Show full text]
  • 2018 Farm Bill Primer: Hemp Cultivation and Processing
    January 30, 2019 2018 Farm Bill Primer: Hemp Cultivation and Processing The enacted 2018 farm bill (Agriculture Improvement Act Puerto Rico, any other territory or possession of the United of 2018, P.L. 115-334) includes a number of provisions that States, and Indian tribes. The enacted farm bill authorizes facilitate the commercial cultivation, processing, marketing, appropriations of “such sums as are necessary” to carry out and sale of industrial hemp in the United States. It expands the provision that establishes this regulatory framework. upon hemp-related provisions enacted in the 2014 farm bill (Agricultural Act of 2014, P.L. 113-79) and includes The new regulatory framework for hemp cultivation would provisions that originated from congressional bills, such as involve either a USDA-approved state or tribal government the Hemp Farming Act of 2018 (S. 2667, H.R. 5485). plan or a plan established by the agency. States, territories, and tribal governments wanting to have primary oversight Expanded Definition of Hemp of hemp production within their jurisdictions must submit a The 2018 farm bill expands the definition of hemp, plan to USDA and obtain the agency’s approval (AMA, originally established in statute as part of the 2014 farm bill §297B). Such a plan would cover, for example, information (7 U.S.C. §5940(b)(2)), codified in Section 297A of the about grower location, procedures for testing, inspections, Agricultural Marketing Act of 1946 (AMA). The amended licensing, background checks, disposal of hemp that does definition defines hemp to mean: not meet the legal definition, and enforcement of violations.
    [Show full text]